MiniMed 780G Insulin Pump, REF: MMT-1885, MMT-1886, MMT-1895, MMT-1896

FDA Device Recall #Z-2698-2026 - Class II, May 27, 2026

Recall Summary

Recall Number Z-2698-2026
Classification Class II - Moderate risk
Date Initiated May 27, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic MiniMed, Inc.
Location Northridge, CA
Product Type Devices
Quantity 778

Product Description

MiniMed 780G Insulin Pump, REF: MMT-1885, MMT-1886, MMT-1895, MMT-1896

Reason for Recall

A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis (DKA).

Distribution Pattern

International distribution to the countries of Spain, Great Britain, Netherlands, Italy.

Lot / Code Information

UDI-DI/GTIN: A7630006392701, 00763000521554, 00763000639273, A7630006392301, 00199150035687, A7630007325603, A7630007325601, 00763000639235, A7630007325604, 00763000384289, 00763000521530, A7630007325401, 00763000521547, A7630006392601, A7630006392201, 00763000639228, 00199150035663, 00763000639266, A7630007325404, 00199150035694, 00763000442194, A7630007325403, 00763000521523. Software version 6.62

Other Recalls from Medtronic MiniMed, Inc.

Recall # Classification Product Date
Z-1745-2026 Class II MiniMed 720G Insulin Pump (MMT-1809, MMT-1810, ... Feb 13, 2026
Z-1739-2026 Class II MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, ... Feb 13, 2026
Z-1747-2026 Class II MiniMed 620G Insulin Pump (MMT-1750) Feb 13, 2026
Z-1752-2026 Class II Paradigm REAL-Time Veo Insulin Pump (MMT-554, M... Feb 13, 2026
Z-1749-2026 Class II Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722) Feb 13, 2026

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.